Skip to main content

About Crohn’s Disease

Crohn’s disease is a chronic inflammatory condition that most commonly affects the last segment of the small intestine (ileum) and the first part of the large intestine (caecum), although it can occur in any part of the GIT from the mouth to the anus. It is not uncommon for people with Crohn’s disease to have normal, healthy parts of tissue in between areas of inflammation. This has implications for how Crohn’s disease is treated, especially by surgery. Also, unlike ulcerative colitis, where the inflammation is limited to the innermost lining of the intestinal wall, in Crohn’s disease the inflammation can extend into the deeper layers, which can lead to the development of complications that are quite specific to the condition.

How does Crohn’s disease affect the intestines?

Crohn’s disease affects the GI tract, and the intestinal wall becomes inflamed (red and swollen). The inflammation can penetrate through all layers of the GI tract and may occur at one or more locations in the GI tract, from the mouth right through to the anus, with areas of normal tissue between areas of diseased tissue. Depending on the main areas of the intestine involved in Crohn’s disease, the condition can be referred to as:

  • Ileocolitis: involves the ileum and colon (small and large intestine)
  • Ileitis: involves the ileum only (small intestine only)
  • Crohn’s (granulomatous) colitis: involves the colon only (large intestine only)
  • Gastroduodenal Crohn’s disease: involves the stomach and duodenum (small intestine)
  • Jejunoileitis: involves the jejunum (small intestine only)

Additional Information:

The latest news and Research

Personal Story

I Became a model after having my colon removed

Posted: May 13 2021

By Gaylyn Henderson, as told to Sarah Z. Wexler My road to a Crohn’s diagnosis started when I was 13. I had always wanted to model, but I was sick so often—experiencing chronic loose stool and using the bathroom often—that I didn’t think it was a possibility for me. My pediatrician immediately referred me to […]

Read more

News

‘It’s affected my life in many different ways’

Posted: May 10 2021

By 2022, it’s expected that more than 100,000 people will be living with Crohn’s disease and ulcerative colitis in Australia, according to Crohn’s & Colitis Australia (CCA). As the rate of these inflammatory bowel diseases (IBD) continue to rise, CCA is urging people to share what it’s like to live with these life-long illnesses as […]

Read more

News

PBS listing for Australians with a rare epilepsy condition and ulcerative colitis

Posted: May 10 2021

In a historic first, Australians living with a rare form of epilepsy will have access to a medicinal cannabis drug, which is being listed on Australia’s Pharmaceutical Benefits Scheme (PBS) for the first time. From 1 May 2021, Australians living with Dravet syndrome, will have access to Epidyolex® (cannabidiol), a new treatment used in combination with […]

Read more

Blog

5 Common mistakes that can make ulcerative colitis worse

Posted: May 10 2021

By Meghan Rabbitt When you live with ulcerative colitis (UC), you know that symptoms can return even if you’ve been in remission—and even if you’re doing everything you can to avoid a flare. Yet there are a number of missteps you might not even realize you’re making that can worsen your condition, says Matilda Hagan, M.D., co-director for […]

Read more

Research

Diet–microbiota interactions in inflammatory bowel disease

Accumulating evidence suggests that the gut microbiota plays pivotal roles in the regulation of intestinal homeostasis and IBD pathogenesis.

By Kohei Sugihara and Nobuhiko Kamada  Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic and relapsing inflammatory disorder of the gastrointestinal tract. The prevalence of IBD has been increasing worldwide, affecting about 3 million people in the United States and 2.5 million people in Europe. Although the precise etiology […]

Read more

News

Advancing research of inflammatory intestinal diseases

Posted: May 10 2021

By Anna MacDonald To help advance research of inflammatory intestinal diseases, Emulate recently launched the Colon Intestine-Chip, a comprehensive model that incorporates human colonic organoids and supportive colonic endothelial cells. We spoke to Dr Lorna Ewart, Emulate’s executive vice president of science, to learn more about the limitations of traditional inflammatory intestinal disease models, what makes the […]

Read more